お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
975901

体外診断検査市場の分析:米国

In Vitro Diagnostics - Market Insights - United States

出版日: | 発行: Decision Resources Group - Medtech | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
体外診断検査市場の分析:米国
出版日: 2020年12月14日
発行: Decision Resources Group - Medtech
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

米国の体外診断検査の市場は新型コロナウイルス感染症 (COVID-19) の影響により短期的には打撃を受けるものの、高齢者人口の増加や価値を重視した医療への移行により、予測期間中は緩やかな成長を示す見通しです。診断精度が向上し、ターンアラウンドタイムが短縮された新しい検査の採用が促進されています。

当レポートでは、米国の体外診断検査の市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、検査タイプ別の動向、市場規模の推移・予測、詳細区分別の内訳、競合環境、市場シェア、成長戦略などをまとめています。

米国

概要

エグゼクティブサマリー

主な改訂

COVID-19:影響分析

体外診断市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
  • 競合ハイライト
  • 市場シェア
  • 競合要因・戦略
    • 臨床データ
    • 製品の改善・革新
    • M&A・提携
    • 製品ポートフォリオ管理
  • 市場における展開

臨床化学検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 一般化学試験
    • 糖尿病検査
    • 治療薬モニタリング検査
    • 乱用薬物検査
    • 特定タンパク質検査
    • 心臓マーカー
    • 血液ガス
  • 競合ハイライト
    • 市場シェア
    • 競合因子・戦略

イムノアッセイ検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • アレルギー検査
    • 貧血検査
    • 骨代謝検査
    • 心臓マーカー検査
    • 不妊/ホルモン検査
    • 感染症検査
    • 特定タンパク質
    • 甲状腺検査
    • 腫瘍マーカー検査
  • 競合ハイライト
  • 市場シェア
  • 競合因子・戦略

微生物検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 病理学的培養試験
    • 血液培養検査
    • 同定/抗生物質感受性試験
  • 競合ハイライト
  • 市場シェア
  • 競合因子・戦略

血液・凝固検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 一般的なスクリーニング・抗凝固モニタリング検査
    • プロトロンビン時間検査
    • D-ダイマー検査
    • フィブリン形成・分解試験
  • 競合ハイライト
  • 市場シェア
  • 競合因子・戦略

分子診断検査市場

  • 市場のハイライト
  • 市場の定義
  • 市場予測データ
    • 感染症検査
    • 競合ハイライト
    • 競合因子・戦略
    • 市場シェア

付録

調査手法

目次

While the COVID-19 pandemic will have a negative impact on the US IVD market in the near term, the market will nonetheless exhibit moderate growth over the forecast period, driven by the aging US population and the shift toward value-based health care, which will fuel uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IVDs in the US across a 10-year period.

The COVID-19 pandemic will negatively impact the US IVD market to some extent.

  • Which test types and segments will be most impacted?
  • At what pace will the IVD market recover?

The use of MDx tests will expand rapidly over the forecast period.

  • Which MDx tests will experience the highest growth throughout the forecast period?
  • How will adoption of MDx tests affect the other test segments in the IVD market?

The PAMA reimbursement revision will promote widespread pricing pressures and increasing laboratory consolidation in the US.

  • How must vendors adjust their strategies to adapt to this trend?
  • How will the growth prospects of the market be affected?
  • How will test volumes between the different facility types be affected?

The IVD competitive landscape consists of large MNCs as well as smaller niche competitors specializing in specific segments and diseases.

  • How do strategies differ between MNCs and smaller companies in this space?
  • What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?

Table of Contents

United States

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Procedures Covered
  • Products Covered

Key Report Updates

COVID-19 Analysis

  • Market Impact
  • Guidance and Recommendations
  • Major Market Forecast Changes and Assumptions
  • Competitive Impact

In Vitro Diagnostics Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Clinical Data
    • Product Improvements and Innovations
    • Mergers, Acquisitions, and Partnerships
    • Product Portfolio Management
  • Market Developments

Clinical Chemistry Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • General Chemistry Tests
    • Diabetes Tests
    • Therapeutic Drug Monitoring Tests
    • Drug of Abuse Testing
    • Specific Protein Tests
    • Cardiac Marker
    • Blood Gas
  • Competitive Highlights
    • Market Shares
    • Competitive Factors and Strategies

Immunoassay Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Allergy Tests
    • Anemia Tests
    • Bone Metabolism Tests
    • Cardiac Marker Tests
    • Fertility/Hormone Tests
    • Infectious Disease Tests
    • Specific Protein
    • Thyroid Tests
    • Tumor Marker Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Microbiology Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Pathological Culture Tests
    • Blood Culture Tests
    • Identification/Antibiotic Susceptibility Testing
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Hematology and Coagulation Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • General Screening and Anticoagulation Monitoring Tests
    • Prothrombin Time Tests
    • D-Dimer Tests
    • Fibrin Formation and Degradation Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Molecular Diagnostic Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Infectious Disease Tests
    • Competitive Highlights
    • Competitive Factors and Strategies
    • Market Shares

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
    • Research Methodology
    • Marketrack Methodology
    • PriceTrack Methodology
    • Forecast Methodology
  • Supplemental Country Coverage Methodology
    • Base-Year Ratio Analysis
    • Market Forecasting

Tables and Figures

  • Factors Impacting the IVD Market, by Application, US
  • IVD Market, by Application, US (USD), 2019-2029
  • IVD Market Landscape, US (USD), 2019 and 2029
  • Competitive Factors and Strategies, by Product Type, US
  • IVD Test Revenue Market Share Rankings, by Application, US, 2018 (market share rankings di...
  • Companies Mentioned
  • Recent Events in the IVD Market, US
  • IVD Procedures Covered, US
  • IVD Products Covered, US
  • COVID-19 Impact Assessment Summary, IVD Market, US
  • Guidance and Recommendations for IVD Procedures
  • IVD Market, by Application, US (USD), 2019-2029 (Excluding COVID-19 Impact)
  • IVD Market, by Application, US (USD), 2019-2029 (Including COVID-19 Impact)
  • COVID-19 Competitive Factors and Strategies, IVD Market, US
  • COVID-19 Impact by Competitor, IVD Market, US
  • Factors Impacting the IVD Market, by Application, US
  • IVD Market, by Application, US (USD), 2019-2029
  • IVD Market, by Product Type, US (USD), 2019-2029
  • IVD Market, by Setting, US (USD), 2019-2029
  • IVD Market, by Application, US (USD), 2019-2029
  • IVD Test Market, by Application, US (USD), 2019-2029
  • IVD Instrumentation Market, by Application, US (USD), 2019-2029
  • IVD Test Revenue Market Shares, US, 2018 (market share rankings displayed are from the pre...
  • IVD Test Revenue Market Shares, by Application, US, 2018 (market share rankings displayed ...
  • Competitive Factors and Strategies, by Product Type, US
  • Recent Events in the IVD Market, US
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2029
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2029
  • Clinical Chemistry Test Market, by Setting, US (USD), 2019-2029
  • Clinical Chemistry Test Market, by Test Type, US (USD), 2019-2029
  • Alanine Aminotransferase Tests, by Setting, US, 2019-2029
  • Alkaline Phosphatase Tests, by Setting, US, 2019-2029
  • Aspartate Aminotransferase Tests, by Setting, US, 2019-2029
  • Bilirubin Tests, by Setting, US, 2019-2029
  • Calcium Tests, by Setting, US, 2019-2029
  • Comprehensive Metabolic Panel Tests, by Setting, US, 2019-2029
  • Creatinine Tests, by Setting, US, 2019-2029
  • Electrolyte Panel Tests, by Setting, US, 2019-2029
  • Hepatic Panel Tests, by Setting, US, 2019-2029
  • Human Chorionic Gonadotropin Tests, by Setting, US, 2019-2029
  • Lactate Tests, by Setting, US, 2019-2029
  • Lactate Dehydrogenase Tests, by Setting, US, 2019-2029
  • Lipase Tests, by Setting, US, 2019-2029
  • Lipid Panel Tests, by Setting, US, 2019-2029
  • Magnesium Tests, by Setting, US, 2019-2029
  • Metabolic Panel including Total Calcium Tests, by Setting, US, 2019-2029
  • Phosphorus Tests, by Setting, US, 2019-2029
  • Potassium Tests, by Setting, US, 2019-2029
  • Total Protein Tests, by Setting, US, 2019-2029
  • Uric Acid Tests, by Setting, US, 2019-2029
  • Other General Chemistry Tests, by Setting, US, 2019-2029
  • Blood Glucose (Non-Reagent-Strip) Tests, by Setting, US, 2019-2029
  • Blood Glucose Reagent Strip Tests, by Setting, US, 2019-2029
  • Glucose Tolerance Tests, by Setting, US, 2019-2029
  • HbA1c Tests, by Setting, US, 2019-2029
  • Insulin Tests, by Setting, US, 2019-2029
  • Microalbumin Quantitative Tests, by Setting, US, 2019-2029
  • Urine Glucose Tests, by Setting, US, 2019-2029
  • Other Diabetes Tests, by Setting, US, 2019-2029
  • Carbamazepine Tests, by Setting, US, 2019-2029
  • Cyclosporine Tests, by Setting, US, 2019-2029
  • Digoxin Tests, by Setting, US, 2019-2029
  • Phenobarbital Tests, by Setting, US, 2019-2029
  • Phenytoin (Total) Tests, by Setting, US, 2019-2029
  • Tacrolimusl Tests, by Setting, US, 2019-2029
  • Theophylline Tests, by Setting, US, 2019-2029
  • Valproic Acid (Total) Tests, by Setting, US, 2019-2029
  • Vancomycin Tests, by Setting, US, 2019-2029
  • Other TDM Tests, by Setting, US, 2019-2029
  • Ethanol Tests, by Setting, US, 2019-2029
  • Acetaminophen Tests, by Setting, US, 2019-2029
  • Salicylate Tests, by Setting, US, 2019-2029
  • Antinuclear Antibody Tests, by Setting, US, 2019-2029
  • Haptoglobin Tests, by Setting, US, 2019-2029
  • Homocysteine Tests, by Setting, US, 2019-2029
  • Prealbumin Tests, by Setting, US, 2019-2029
  • Rheumatoid Factor Tests, by Setting, US, 2019-2029
  • Somatomedin Tests, by Setting, US, 2019-2029
  • Other Specific Protein Tests, by Setting, US, 2019-2029
  • Apolipoprotein Tests, by Setting, US, 2019-2029
  • Cholesterol Tests, by Setting, US, 2019-2029
  • C-Reactive Protein Tests, by Setting, US, 2019-2029
  • High Sensitivity C-Reactive Protein Tests, by Setting, US, 2019-2029
  • Low Density Lipoprotein Tests, by Setting, US, 2019-2029
  • Triglyceride Tests, by Setting, US, 2019-2029
  • Other Cardiac Marker Tests, by Setting, US, 2019-2029
  • Arterial Blood Gas Tests, by Setting, US, 2019-2029
  • Chloride Tests, by Setting, US, 2019-2029
  • Urea Nitrogen Tests, by Setting, US, 2019-2029
  • Other Blood Gas Tests, by Setting, US, 2019-2029
  • Clinical Chemistry Test Revenue Market Shares, US, 2018 (market share rankings displayed a...
  • Clinical Chemistry Test Revenue Market Shares, by Product Type, US, 2018 (market share ran...
  • Competitive Factors and Strategies, US
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2029
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2029
  • Immunoassay Test Market, by Setting, US (USD), 2019-2029
  • Immunoassay Test Market, by Test Type, US (USD), 2019-2029
  • Allergy IgA, IgD, IgG, IgM Tests, by Setting, US, 2019-2029
  • Allergy IgE Tests, by Setting, US, 2019-2029
  • Immunoglobulin Subclasses Tests, by Setting, US, 2019-2029
  • Erythropoietin Tests, by Setting, US, 2019-2029
  • Ferritin Tests, by Setting, US, 2019-2029
  • Intrinsic Factor Antibody Tests, by Setting, US, 2019-2029
  • Iron Tests, by Setting, US, 2019-2029
  • Iron Binding Capacity Tests, by Setting, US, 2019-2029
  • Vitamin B-12 Tests, by Setting, US, 2019-2029
  • HGH Tests, by Setting, US, 2019-2029
  • Parathormone Tests, by Setting, US, 2019-2029
  • Vitamin D 25 Hydroxy Tests, by Setting, US, 2019-2029
  • Creatine Kinase Tests, by Setting, US, 2019-2029
  • CK-MB Tests, by Setting, US, 2019-2029
  • BNP Tests, by Setting, US, 2019-2029
  • Troponin Tests, by Setting, US, 2019-2029
  • ACTH Tests, by Setting, US, 2019-2029
  • Estradiol Tests, by Setting, US, 2019-2029
  • FSH Tests, by Setting, US, 2019-2029
  • LH Tests, by Setting, US, 2019-2029
  • Progesterone Tests, by Setting, US, 2019-2029
  • Prolactin Tests, by Setting, US, 2019-2029
  • Testosterone Tests, by Setting, US, 2019-2029
  • Other Fertility/Hormone Tests, by Setting, US, 2019-2029
  • Acute Hepatitis Tests, by Setting, US, 2019-2029
  • CMV Tests, by Setting, US, 2019-2029
  • Epstein-Barr Virus Tests, by Setting, US, 2019-2029
  • Hepatitis A Tests, by Setting, US, 2019-2029
  • Hepatitis B Tests, by Setting, US, 2019-2029
  • Hepatitis C Tests, by Setting, US, 2019-2029
  • HIV-1/HIV-2 Tests, by Setting, US, 2019-2029
  • HSV Tests, by Setting, US, 2019-2029
  • HSV Type 2 Tests, by Setting, US, 2019-2029
  • HTLV or HIV Tests, by Setting, US, 2019-2029
  • Influenza A/B Tests, by Setting, US, 2019-2029
  • Lyme Disease Tests, by Setting, US, 2019-2029
  • Microsomal Antibodies Tests, by Setting, US, 2019-2029
  • Nephelometry Tests, by Setting, US, 2019-2029
  • Parvovirus Tests, by Setting, US, 2019-2029
  • Respiratory Syncytial Virus Tests, by Setting, US, 2019-2029
  • Rotavirus Tests, by Setting, US, 2019-2029
  • Rubella Tests, by Setting, US, 2019-2029
  • Treponema Pallidum Tests, by Setting, US, 2019-2029
  • Varicella-Zoster Virus Tests, by Setting, US, 2019-2029
  • Other Infectious Disease Tests, by Setting, US, 2019-2029
  • Albumin Tests, by Setting, US, 2019-2029
  • Alpha-1 Antitrypsin Tests, by Setting, US, 2019-2029
  • Gamma-Glutamyl Transferase Tests, by Setting, US, 2019-2029
  • Thyroxine (Free) Tests, by Setting, US, 2019-2029
  • Thyroglobulin Tests, by Setting, US, 2019-2029
  • Thyroid (T3) Tests, by Setting, US, 2019-2029
  • Thyroid (T3 or T4) Tests, by Setting, US, 2019-2029
  • Thyroxine (Total) Tests, by Setting, US, 2019-2029
  • TSH Tests, by Setting, US, 2019-2029
  • Alpha-Fetoprotein Serum Tests, by Setting, US, 2019-2029
  • Beta-2 Microglobulin Tests, by Setting, US, 2019-2029
  • CA 125 Tests, by Setting, US, 2019-2029
  • CA 15-3 Tests, by Setting, US, 2019-2029
  • CA 19-9 Tests, by Setting, US, 2019-2029
  • Carcinoembryonic Antigen Tests, by Setting, US, 2019-2029
  • PSA (Free) Tests, by Setting, US, 2019-2029
  • PSA (Total) Tests, by Setting, US, 2019-2029
  • Other Tumor Marker Tests, by Setting, US, 2019-2029
  • Immunoassay Test Revenue Market Shares, US, 2018 (market share rankings displayed are from...
  • Immunoassay Test Revenue Market Shares, by Product Type, US, 2018 (market share rankings d...
  • Competitive Factors and Strategies, US
  • Microbiology Test Market, by Product Type, US (USD), 2019-2029
  • Microbiology Test Market, by Product Type, US (USD), 2019-2029
  • Microbiology Test Market, by Setting, US (USD), 2019-2029
  • Microbiology Test Market, by Test Type, US (USD), 2019-2029
  • Salmonella and Shigella (Stool Culture) Tests, by Setting, US, 2019-2029
  • Other Pathogen (Stool Culture) Tests, by Setting, US, 2019-2029
  • Mycobacteria Culture Tests, by Setting, US, 2019-2029
  • Aerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2029
  • Anaerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2029
  • Urine Bacteria Culture Tests, by Setting, US, 2019-2029
  • Blood Culture Tests, by Setting, US, 2019-2029
  • Aerobic Culture Identification Tests, by Setting, US, 2019-2029
  • Anaerobic Culture Identification Tests, by Setting, US, 2019-2029
  • Immunologic Culture Identification Tests, by Setting, US, 2019-2029
  • MIC Tests, by Setting, US, 2019-2029
  • Microbe Susceptible Disk Tests, by Setting, US, 2019-2029
  • Presumptive Pathogenic Organisms Culture Tests, by Setting, US, 2019-2029
  • Yeast Identification Tests, by Setting, US, 2019-2029
  • Other ID/AST Tests, by Setting, US, 2019-2029
  • Microbiology Test Revenue Market Shares, US, 2018 (market share rankings displayed are fro...
  • Microbiology Test Revenue Market Shares, US, 2018 (market share rankings displayed are fro...
  • Competitive Factors and Strategies, US
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2029
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2029
  • Hematology and Coagulation Test Market, by Setting, US (USD), 2019-2029
  • Hematology and Coagulation Test Market, by Test Type, US (USD), 2019-2029
  • Automated Platelet Count Tests, by Setting, US, 2019-2029
  • Blood Smear with Differential White Blood Cell Count Tests, by Setting, US, 2019-2029
  • Complete CBC Automated Tests, by Setting, US, 2019-2029
  • Complete CBC with Automated White Blood Cell Count Tests, by Setting, US, 2019-2029
  • Erythrocyte Sedimentation Rate Tests, by Setting, US, 2019-2029
  • Hematocrit Tests, by Setting, US, 2019-2029
  • Hemoglobin Tests, by Setting, US, 2019-2029
  • Leukocyte Tests, by Setting, US, 2019-2029
  • Red Blood Cell Count Tests, by Setting, US, 2019-2029
  • Reticulocyte Tests, by Setting, US, 2019-2029
  • Sickle Cell Screen Tests, by Setting, US, 2019-2029
  • Transferrin Tests, by Setting, US, 2019-2029
  • Other General Screening and Anticoagulation Monitoring Tests, by Setting, US, 2019-2029
  • Prothrombin Time Tests, by Setting, US, 2019-2029
  • D-Dimer Tests, by Setting, US, 2019-2029
  • aPTT Tests, by Setting, US, 2019-2029
  • Fibrinogen Tests, by Setting, US, 2019-2029
  • Hematology and Coagulation Test Revenue Market Shares, US, 2018 (market share rankings dis...
  • Hematology and Coagulation Test Revenue Market Shares, by Product Type, US, 2018 (market s...
  • Competitive Factors and Strategies, US
  • MDx Test Market, by Product Type, US (USD), 2019-2029
  • MDx Test Market, by Product Type, US (USD), 2019-2029
  • MDx Test Market, by Setting, US (USD), 2019-2029
  • Chlamydia Tests, by Setting, US, 2019-2029
  • Clostridium Difficile Tests, by Setting, US, 2019-2029
  • Gonorrhea Tests, by Setting, US, 2019-2029
  • Hepatitis C Tests, by Setting, US, 2019-2029
  • HIV-1 Tests, by Setting, US, 2019-2029
  • HPV Tests, by Setting, US, 2019-2029
  • HSV Tests, by Setting, US, 2019-2029
  • Staphylococcus Aureus Tests, by Setting, US, 2019-2029
  • Streptococcus Group A Tests, by Setting, US, 2019-2029
  • Unspecified Infectious Agent Tests, by Setting, US, 2019-2029
  • Other Infectious Disease Tests, by Setting, US, 2019-2029
  • Competitive Factors and Strategies, US
  • MDx Test Revenue Market Shares, US, 2018 (market share rankings displayed are from the pre...
  • MDx Test Revenue Market Shares, by Product Type, US, 2018 (market share rankings displayed...
  • Abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.